Endogenous lipoproteins impact the response to endotoxin in humans
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether endogenous lipoproteins can abrogate the host response to lipopolysaccharide (LPS) in vivo. DESIGN: Randomized, placebo-controlled study. SETTING: Urban public hospital with academic affiliation. SUBJECTS: Eighteen healthy, normolipidemic, normal weight volunteers, 21-35 yrs of age. INTERVENTIONS: Fasting and postprandial (hypertriglyceridemic) subjects were injected with endotoxin (LPS, Lot EC-5, 4 ng/kg = 20 endotoxin units/kg) as either a bolus or following preincubation of the LPS with autologous whole blood vs. saline. In addition, LPS-induced cytokine production was determined ex vivo to examine the capacity of fasting vs. hypertriglyceridemic whole blood to attenuate the effect of large, potentially lethal concentrations of LPS in humans. MEASUREMENTS: Vital signs were recorded and serial blood samples analyzed for changes in white blood cell count, cytokine, and stress hormone levels over 24 hrs. The distribution of lipoproteins in fasting and postprandial blood after preincubation was determined using 125I-LPS. MAIN RESULTS: Endogenous lipoproteins abrogated the host response to LPS in vivo, but only after preincubation with the LPS. Peak oral temperature (p < .05) and white blood cell count (p < .05), and plasma tumor necrosis factor (TNF)-alpha (p < .01) and adrenocorticotropic hormone levels (p < .03) were significantly reduced in volunteers injected with LPS preincubated with whole blood vs. LPS preincubated with saline. Approximately 80% of the LPS was bound to lipoproteins after preincubation with either fasting or hypertriglyceridemic blood. Thus, protection was associated with lipoprotein binding. In addition, hypertriglyceridemic but not fasting blood inhibited the ex vivo TNF-alpha response to large, highly toxic doses of LPS (p < .05). Without the preincubation of lipoproteins with LPS, there was a trend for an exaggerated clinical and TNF-alpha response in the hypertriglyceridemic subjects. CONCLUSION: Preincubation of LPS with whole blood promotes lipoprotein-LPS binding and is associated with an attenuated response to this toxic macromolecule. Although the clinical relevance of these data requires further elucidation, our results continue to support a lipid-based therapeutic strategy to combat gram-negative sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · cited 1×
“To determine whether the induction of hypertriglyceridemia could ameliorate the effects of LPS in humans, we used a standardized methodology for the intravenous injection of lipopolysaccharide (31).”
MethodReceptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“The other protein is lipopolysaccharide binding protein (LBP), a class I acute phase reactant (1).”
BackgroundOpal, S. M., Scannon, P. J., Vincent, J., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315093 · Cited by 609
Lumsden, A. B., Henderson, M. J., & Kutner, M. H. (1988) · Hepatology · doi:10.1002/hep.1840080207 · Cited by 427 · cited 1×
“illness, equivalent or higher levels of circulating LPS have been documented in patients with chronic liver disease who were nevertheless medically stable (33, 34).”
BackgroundRensen, P. C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., & Berkel, T. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119427 · Cited by 113
Cited by
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
“When LPS was preincubated with fasting or hypertriglyceridemic whole blood, the majority of LPS was bound to lipoproteins and the host response to LPS was attenuated (319).”
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Mesotten, D., Swinnen, J. V., Vanderhoydonc, F., Wouters, P. J., & Van den Berghe, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030760 · Cited by 288
Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects.
Pluess, T.-T., Hayoz, D., Berger, M. M., Tappy, L., Revelly, J.-P., Michaeli, B., Carpentier, Y. A., & Chioléro, R. L. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0591-5 · Cited by 94
“Finally lipid emulsions have been shown to blunt the response to LPS in vitro and in vivo [30].”
Background
Metadata
- Authors
- Harris, H. W., Johnson, J. A., & Wigmore, S. J.
- Venue
- Critical Care Medicine
- Published
- 2002-01
- Volume
- 30
- Issue
- 1
- Pages
- 23-31
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2013825016
- Cited by
- 56
- References
- 5
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endogenous lipoproteins impact the response to endotoxin in humans. https://app.cochat.ai/papers/10.1097/00003246-200201000-00004
- The paper
- Harris, H. W., Johnson, J. A., & Wigmore, S. J. (2002). Endogenous lipoproteins impact the response to endotoxin in humans. Critical Care Medicine. https://doi.org/10.1097/00003246-200201000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.